Senior insider sale
Ch. Operating & Financial Off. at OLEMA PHARMACEUTICALS, INC. — senior position signals high conviction
$2.98M
103.82K shares
KOVACS SHANE WILLIAM CHARLES plans to sell 103.82K shares of OLEMA PHARMACEUTICALS, INC. valued at approximately $2.98M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
ESPP Purchase
Cash
ESPP Purchase
Cash
ESPP Purchase
Cash
Open Market Purchase
Cash
Open Market Purchase
Cash
Restricted Stock Vesting
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/10/2024 | Restricted Stock Vesting Compensation | 15.77K | — |
12/9/2024 | Restricted Stock Vesting Compensation | 16.02K | — |
6/28/2024 | ESPP Purchase Cash | 471.00 | — |
11/15/2023 | ESPP Purchase Cash | 1.75K | — |
5/15/2023 | ESPP Purchase Cash | 9.03K | — |
4/6/2023 | Open Market Purchase Cash | 10K | — |
9/2/2022 | Open Market Purchase Cash | 20K | — |
6/15/2020 | Restricted Stock Vesting Compensation | 26.96K | — |
| Total | 100K | ||
Completed
Units to sell
3.82K
Market value
$107.1K
Planned — Approximate Date
Units to sell
100K
Market value
$2.87M
Units
103.82K
Value
$2.98M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/13/2026 | 3.82K | $107.1K | — | Completed |
| Planned — Approximate Date | ||||
1/15/2026 | 100K | $2.87M | NASDAQ | Planned |
| Total | 103.82K | $2.98M | ||